ISOLATION AND EXPRESSION OF CDNA CLONES FOR RIF

Information

  • Research Project
  • 3492630
  • ApplicationId
    3492630
  • Core Project Number
    R43CA053040
  • Full Project Number
    1R43CA053040-01A1
  • Serial Number
    53040
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/1991 - 33 years ago
  • Project End Date
    11/30/1991 - 32 years ago
  • Program Officer Name
  • Budget Start Date
    6/1/1991 - 33 years ago
  • Budget End Date
    11/30/1991 - 32 years ago
  • Fiscal Year
    1991
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    5/30/1991 - 33 years ago

ISOLATION AND EXPRESSION OF CDNA CLONES FOR RIF

Cytotoxic activated macrophages secrete soluble factors that have a variety of effects on tumor cells. Included in the tumor cell response are the inhibition of mitochondrial respiration and inhibition of DNA synthesis. A monokine called RIF, which was found to reproduce these effects in vitro, has been characterized and the amino acid sequence of the amino-terminus determined. The isolation and verification of the cDNA for RIF is the primary focus of this project. Based on the sequence obtained from the 80kD protein purified in the RIF preparations, a synthetic peptide was constructed and antibodies against the peptide were produced. This antibody probe and an antiserum against a preparation of RIF protein will be used to screen a lambda expression library in order to isolate a cDNA clone corresponding to the RIF protein. The cDNA will be fully characterized and expression studies will be initiated. The availability of recombinant protein and cDNA clones will permit a second phase of studies which will entail expression studies in mammalian systems, animal- tumor model studies of recombinant proteins, and mechanism studies of the recombinant protein.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    396
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    ARONEX PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    THE WOODLANDS
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    77380
  • Organization District
    UNITED STATES